Compare CRMD & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRMD | CIVB |
|---|---|---|
| Founded | 2006 | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.9M | 461.6M |
| IPO Year | 2009 | 2012 |
| Metric | CRMD | CIVB |
|---|---|---|
| Price | $6.34 | $22.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $14.67 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 1.4M | 60.7K |
| Earning Date | 06-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.24% |
| EPS Growth | ★ 780.00 | 31.34 |
| EPS | 2.04 | ★ 2.64 |
| Revenue | ★ $311,709,000.00 | $19,023,000.00 |
| Revenue This Year | $1.10 | $15.24 |
| Revenue Next Year | N/A | $6.52 |
| P/E Ratio | ★ $3.16 | $8.38 |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $5.60 | $17.47 |
| 52 Week High | $17.43 | $25.59 |
| Indicator | CRMD | CIVB |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 34.43 |
| Support Level | $6.13 | $21.42 |
| Resistance Level | $7.44 | $22.52 |
| Average True Range (ATR) | 0.29 | 0.69 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 18.42 | 16.63 |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.